1. Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients 
D. He, S. Guo, P. Zhu, S. Tao, M. Li, H. Huang, J. Wang, Y. Wang, M. Ding 
Clinical Microbiology and Infection 
Volume 20, Issue 10, Pages O687-O693 (October 2014)
DOI: /
Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Survival functions for the cumulative rate of sustained response and the time of sustained response after NUC discontinuation. The cumulative rate of sustained response was 91.8% (a). No significant difference in the cumulative rate of sustained response was observed for sex (b, p = 0.620), age (c, p = 0.061), baseline ALT (d, p = 0.632), NUCs (e, p = 0.760) or genotype (f, p = 0.202).
Clinical Microbiology and Infection  , O687-O693DOI: ( / )
Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions